drug · small molecule
patient view →ILLUCCIX
Marketedupdated 2mo agoby $TLX Telix Pharmaceuticals Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 5 investigational indications.
all catalysts(4)
approval · 4
Dec 17, 2021
approval
ILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approval
ILLUCCIX
→
Mar 15, 2023
approval
ILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approval
ILLUCCIX
→
Sep 11, 2025
approval
ILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approval
ILLUCCIX
→
Dec 5, 2025
approval
ILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approval
ILLUCCIX
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that